Cargando…
Intraventricular injections of mesenchymal stem cells activate endogenous functional remyelination in a chronic demyelinating murine model
Current treatments for demyelinating diseases are generally only capable of ameliorating the symptoms, with little to no effect in decreasing myelin loss nor promoting functional recovery. Mesenchymal stem cells (MSCs) have been shown by many researchers to be a potential therapeutic tool in treatin...
Autores principales: | Cruz-Martinez, P, González-Granero, S, Molina-Navarro, M M, Pacheco-Torres, J, García-Verdugo, J M, Geijo-Barrientos, E, Jones, J, Martinez, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917663/ https://www.ncbi.nlm.nih.gov/pubmed/27171265 http://dx.doi.org/10.1038/cddis.2016.130 |
Ejemplares similares
-
Corrigendum: Intraventricular injections of mesenchymal stem cells activate endogenous functional remyelination in a chronic demyelinating murine model
por: Cruz-Martinez, Pablo, et al.
Publicado: (2017) -
Mesenchymal stromal-cell transplants induce oligodendrocyte progenitor migration and remyelination in a chronic demyelination model
por: Jaramillo-Merchán, J, et al.
Publicado: (2013) -
Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
por: Keough, Michael B., et al.
Publicado: (2015) -
Experimental models of demyelination and remyelination()
por: Torre-Fuentes, L., et al.
Publicado: (2020) -
Conventional and quantitative MRI in a novel feline model of demyelination and endogenous remyelination
por: Field, Aaron S., et al.
Publicado: (2018)